Exelixis | Attività Correnti

Prezzo Delle Azioni
44.06
Cambio Giornaliero
-0.22 -0.50%
Mensile
3.28%
Annuale
13.88%
Q1 Previsione
42.70




Attività Correnti Cambiamento Data
Acadia Pharmaceuticals USD 1.06B 14.31M 2025-12
Agios Pharmaceuticals USD 942.05M 91.06M 2025-12
Akebia Therapeutics USD 252.96M 5.38M 2025-12
Amgen USD 29.06B 1.17B 2025-12
AstraZeneca USD 28.72B 1.22B 2025-12
Bayer EUR 32.88B 873M 2025-09
BioMarin Pharmaceutical USD 3.95B 98.95M 2025-12
Bristol-Myers Squibb USD 35.63B 2.41B 2025-09
Cytokinetics USD 916.97M 60.37M 2025-12
Eisai JPY 840.88B 50.18B 2025-12
Eli Lilly USD 55.63B 6.44B 2025-12
Esperion Therapeutics USD 360.46M 17.87M 2025-09
Exelixis USD 1.44B 41.03M 2025-12
Genmab DKK 3.91B 127M 2025-06
Glaxosmithkline GBP 23.98B 6.31B 2025-09
Incyte USD 5.02B 746.01M 2025-12
Ionis Pharmaceuticals USD 2.99B 471.01M 2025-12
MacroGenics USD 232.09M 27.15M 2025-09
Merck USD 47.56B 10.49B 2025-09
Moderna USD 6.54B 54M 2025-12
Nektar Therapeutics USD 281.36M 94.79M 2025-09
Neurocrine Biosciences USD 2.52B 364.3M 2025-12
Novartis USD 28.2B 2.26B 2025-09
Pfizer USD 46.92B 3.22B 2025-09
Puma Biotechnology USD 143.58M 7M 2025-09
Sanofi EUR 30.95B 8.99B 2025-12
Takeda JPY 3.12T 195.82B 2025-12
Ultragenyx Pharmaceutical USD 643.21M 76.58M 2025-09
Xencor USD 599.82M 81.38M 2025-12


Exelixis Attività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2026.